Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 883 | 844 | 859 | 1,342 | 1,399 |
| Gross Profit | 883 | 844 | 859 | 1,342 | 1,399 |
| Operating Expenses | 1,551 | 1,630 | 1,621 | 1,824 | 1,896 |
| Operating Income | -668 | -786 | -762 | -482 | -497 |
| Other Income | 0 | 0 | -5,020 | 4,510 | -6,609 |
| Pre-tax Income | -668 | -786 | -5,782 | 4,028 | -7,106 |
| Net Income Continuous | -668 | -786 | -5,782 | 4,028 | -7,106 |
| Net Income | $-668 | $-786 | $-5,782 | $4,028 | $-7,106 |
| EPS Basic Total Ops | 0.01 | -0.01 | -0.06 | 0.03 | -0.05 |
| EPS Basic Continuous Ops | -0.03 | -0.01 | -0.06 | 0.06 | -0.12 |
| EPS Diluted Total Ops | 0.04 | -0.01 | -0.06 | 0.00 | -0.04 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | -0.06 | 0.06 | -0.10 |
| EBITDA(a) | $-668 | $-786 | $-762 | $-482 | $-497 |